1. Home
  2. CRGY vs WVE Comparison

CRGY vs WVE Comparison

Compare CRGY & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGY
  • WVE
  • Stock Information
  • Founded
  • CRGY 1986
  • WVE 2012
  • Country
  • CRGY United States
  • WVE Singapore
  • Employees
  • CRGY N/A
  • WVE N/A
  • Industry
  • CRGY Oil & Gas Production
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRGY Energy
  • WVE Health Care
  • Exchange
  • CRGY Nasdaq
  • WVE Nasdaq
  • Market Cap
  • CRGY 1.6B
  • WVE 1.7B
  • IPO Year
  • CRGY N/A
  • WVE 2015
  • Fundamental
  • Price
  • CRGY $8.38
  • WVE $5.92
  • Analyst Decision
  • CRGY Buy
  • WVE Strong Buy
  • Analyst Count
  • CRGY 11
  • WVE 11
  • Target Price
  • CRGY $17.56
  • WVE $22.00
  • AVG Volume (30 Days)
  • CRGY 5.0M
  • WVE 1.7M
  • Earning Date
  • CRGY 05-05-2025
  • WVE 05-08-2025
  • Dividend Yield
  • CRGY 5.74%
  • WVE N/A
  • EPS Growth
  • CRGY N/A
  • WVE N/A
  • EPS
  • CRGY N/A
  • WVE N/A
  • Revenue
  • CRGY $2,930,919,000.00
  • WVE $108,302,000.00
  • Revenue This Year
  • CRGY $31.77
  • WVE N/A
  • Revenue Next Year
  • CRGY $0.13
  • WVE N/A
  • P/E Ratio
  • CRGY N/A
  • WVE N/A
  • Revenue Growth
  • CRGY 23.01
  • WVE N/A
  • 52 Week Low
  • CRGY $6.83
  • WVE $4.25
  • 52 Week High
  • CRGY $16.94
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • CRGY 38.33
  • WVE 33.76
  • Support Level
  • CRGY $6.83
  • WVE $5.28
  • Resistance Level
  • CRGY $8.09
  • WVE $6.41
  • Average True Range (ATR)
  • CRGY 0.78
  • WVE 0.62
  • MACD
  • CRGY -0.01
  • WVE -0.00
  • Stochastic Oscillator
  • CRGY 33.77
  • WVE 20.51

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: